Idraparinux antithrombotics  

idraparinux      

Select             pdf
Trial Studied trt Control trt patientstagsROB Trial resultMajor bleedingAll cause death

atrial fibrillation  

AMADEUS, 2008      NCTidraparinuxwarfarin standard doseRisk of bias negative 167%12%

pulmonary embolism  

VanGogh PE, 2007    NCTidraparinux (without heparin)heparin/VKARisk of bias negative -49%79%

venous thrombosis  

Van Gogh (subgroup), 2011     idraparinuxstandard treatmentpatients with cancerExploratory negative
VanGogh DVT, 2007    NCTidraparinux (without heparin)heparin/VKAExploratory suggesting-29%3%
VanGogh PE, 2007    NCTidraparinux (without heparin)heparin/VKARisk of bias negative -49%79%